Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Cell Physiol ; 282(3): C472-8, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11832331

ABSTRACT

We previously reported an endogenous, membrane-bound Cu oxidase with homology to ceruloplasmin in BeWo cells, a placental choriocarcinoma cell line. In this previous study, ceruloplasmin immunoreactivity was localized to the perinuclear region and non-brush-border membranes. Here, we show that azide-sensitive oxidase activity is enriched in the same fractions, correlating subcellular localization of enzyme activity with ceruloplasmin immunoreactivity. Expression of the placental Cu oxidase is inversely proportional to Fe status and directly proportional to Cu status at enzyme and protein levels. To identify a role for the Cu oxidase, cells were exposed to (59)Fe-transferrin for 18 h in an environment of 20% O(2) or 5% O(2). At 5% O(2), Cu-deficient cells retain significantly more (59)Fe than control cells. This excess in (59)Fe accumulation is caused by a significant decrease in (59)Fe release. These results indicate that downregulation of the placental Cu oxidase in BeWo cells impairs Fe release. This effect is only apparent in an environment of limited O(2).


Subject(s)
Ceruloplasmin/metabolism , Copper/metabolism , Iron/metabolism , Phenylenediamines/metabolism , Placenta/enzymology , Sarcosine/analogs & derivatives , Animals , Cell Fractionation , Ceruloplasmin/analogs & derivatives , Choriocarcinoma , Deferoxamine/pharmacology , Female , Heterocyclic Compounds/pharmacology , Humans , Iron Chelating Agents/pharmacology , Oxidoreductases/metabolism , Oxygen/metabolism , Placenta/cytology , Placenta/drug effects , Pregnancy , Sarcosine/pharmacology , Tumor Cells, Cultured , Uterine Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL
...